Correlation Between Cardio Diagnostics and Corcept Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Corcept Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Corcept Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Corcept Therapeutics Incorporated, you can compare the effects of market volatilities on Cardio Diagnostics and Corcept Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Corcept Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Corcept Therapeutics.

Diversification Opportunities for Cardio Diagnostics and Corcept Therapeutics

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cardio and Corcept is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Corcept Therapeutics Incorpora in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corcept Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Corcept Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corcept Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Corcept Therapeutics go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and Corcept Therapeutics

Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to under-perform the Corcept Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cardio Diagnostics Holdings is 4.06 times less risky than Corcept Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Corcept Therapeutics Incorporated is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  5,542  in Corcept Therapeutics Incorporated on January 10, 2025 and sell it today you would earn a total of  1,231  from holding Corcept Therapeutics Incorporated or generate 22.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  Corcept Therapeutics Incorpora

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cardio Diagnostics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in May 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Corcept Therapeutics 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Corcept Therapeutics Incorporated are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Corcept Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Cardio Diagnostics and Corcept Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and Corcept Therapeutics

The main advantage of trading using opposite Cardio Diagnostics and Corcept Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Corcept Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corcept Therapeutics will offset losses from the drop in Corcept Therapeutics' long position.
The idea behind Cardio Diagnostics Holdings and Corcept Therapeutics Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance